Prognostic impact of B-cell density in cutaneous melanoma

Cancer Immunology, Immunotherapy

Volumn 60, Issue 12, 2011, Pages 1729-1738

  Ladányi, Andrea ^a   Kiss, Judit ^a   Mohos, Anita ^b   Somlai, Beáta ^b   Liszkay, Gabriella ^a   Gilde, Katalin ^a   Fejős, Zsuzsanna ^a   Gaudi, István ^a   Dobos, Judit ^a   Tímár, József ^b  

^a NATIONAL INSTITUTE OF ONCOLOGY   (Hungary)

^b SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

B cell; Immunohistochemistry; Melanoma; Metastasis; Survival

Indexed keywords

CD134 ANTIGEN; CD20 ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA;

ADOLESCENT; ADULT; AGED; ARTICLE; B LYMPHOCYTE; CANCER GROWTH; CANCER SURVIVAL; CELL AGGREGATION; CELL DENSITY; CELL TYPE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISTANT METASTASIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LYMPH NODE METASTASIS; LYMPHOCYTIC INFILTRATION; MALE; MELANOMA; OUTCOME ASSESSMENT; PRIMARY TUMOR; PRIORITY JOURNAL; PROGNOSIS; SKIN CANCER; T LYMPHOCYTE ACTIVATION; TUMOR ASSOCIATED LEUKOCYTE; TUMOR VOLUME;

EID: 82355169702     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/s00262-011-1071-x     Document Type: Article

References (49)

1. S Vesalainen P Lipponen M Talja K Syrjanen 1994 Histological grade, perineural infiltration, tumour-infiltrating lymphocytes and apoptosis as determinants of long-term prognosis in prostatic adenocarcinoma Eur J Cancer 30A 1797 1803 7880609 10.1016/0959-8049(94)E0159-2 1:STN:280:DyaK2M7os1aguw%3D%3D (Pubitemid 24377155)
2. LP Setälä VM Kosma S Marin PK Lipponen MJ Eskelinen KJ Syrjanen EM Alhava 1996 Prognostic factors in gastric cancer: the value of vascular invasion, mitotic rate and lymphoplasmacytic infiltration Br J Cancer 74 766 772 8795580 10.1038/bjc.1996.434 (Pubitemid 26300769)
3. J Galon A Costes F Sanchez-Cabo A Kirilovsky B Mlecnik C Lagorce-Pagès M Tosolini M Camus A Berger P Wind F Zinzindohué P Bruneval P-H Cugnenc Z Trajanoski W-H Fridman F Pagès 2006 Type, density, and location of immune cells within human colorectal tumors predict clinical outcome Science 313 1960 1964 17008531 10.1126/science.1129139 1:CAS:528:DC%2BD28XhtVSnsrnK (Pubitemid 44498003)
4. KI Al-Shibli T Donnem S Al-Saad M Persson RM Bremnes L-T Busund 2008 Prognostic effect of epithelial and stromal lymphocyte infiltration in non-small cell lung cancer Clin Cancer Res 14 5220 5227 18698040 10.1158/1078-0432.CCR- 08-0133 1:CAS:528:DC%2BD1cXpslKgu7Y%3D
5. HE Lee SW Chae YJ Lee MA Kim HS Lee BL Lee WH Kim 2008 Prognostic implications of type and density of tumour-infiltrating lymphocytes in gastric cancer Br J Cancer 99 1704 1711 18941457 10.1038/sj.bjc.6604738 1:CAS:528:DC%2BD1cXhtlGrur%2FE
6. + T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer Cancer Res 58 3491 3494 9721846 1:CAS:528:DyaK1cXlsFajsb4%3D (Pubitemid 28376536)
7. + /regulatory T cell ratio are associated with favorable prognosis in ovarian cancer Proc Natl Acad Sci USA 102 18538 18543 16344461 10.1073/pnas.0509182102 1:CAS:528:DC%2BD28Xpt1Om (Pubitemid 43011261)
8. WH Clark Jr DE Elder D Guerry IV LE Braitman BJ Trock D Schultz M Synnestvedt AC Halpern 1989 Model predicting survival in stage I melanoma based on tumor progression J Natl Cancer Inst 81 1893 1904 2593166 10.1093/jnci/81.24.1893 (Pubitemid 20026075)
9. CG Clemente MC Mihm Jr R Bufalino S Zurrida P Collini N Cascinelli 1996 Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma Cancer 77 1303 1310 8608507 10.1002/(SICI)1097- 0142(19960401)77:7<1303::AID-CNCR12>3.0.CO;2-5 1:STN:280: DyaK287pslChtA%3D%3D (Pubitemid 26102328)
10. RL Barnhill JA Fine GC Roush M Berwick 1996 Predicting five-year outcome for patients with cutaneous melanoma in a population-based study Cancer 78 427 432 8697387 10.1002/(SICI)1097-0142(19960801)78:3<427::AID-CNCR8>3.0.CO;2- G 1:STN:280:DyaK28zitVGksw%3D%3D (Pubitemid 26250527)
11. RC Taylor A Patel KS Panageas KJ Busam MS Brady 2007 Tumor-infiltrating lymphocytes predict sentinel lymph node positivity in patients with cutaneous melanoma J Clin Oncol 25 869 875 17327608 10.1200/JCO.2006.08.9755 (Pubitemid 350002888)
12. F Hillen CIM Beaten A van de Winkel D Creytens DWJ van der Schaft V Winnepenninckx AW Griffioen 2008 Leukocyte infiltration and tumor cell plasticity are parameters of aggressiveness in primary cutaneous melanoma Cancer Immunol Immunother 57 97 106 17602225 10.1007/s00262-007-0353-9 (Pubitemid 350043652)
13. RL Ridolfi PP Rosen A Port D Kinne V Miké 1977 Medullary carcinoma of the breast: a clinicopathologic study with 10 year follow-up Cancer 40 1365 1385 907958 10.1002/1097-0142(197710)40:4<1365::AID-CNCR2820400402>3.0. CO;2-N 1:STN:280:DyaE1c%2FgtFKhsQ%3D%3D (Pubitemid 8221704)
14. JC Whelchel SE Farah IW McLean MN Burnier 1993 Immunohistochemistry of infiltrating lymphocytes in uveal malignant melanoma Invest Ophthalmol Vis Sci 34 2603 2606 8325762 1:STN:280:DyaK3szhsFehsw%3D%3D (Pubitemid 23206493)
15. JA Coronella-Wood EM Hersh 2003 Naturally occurring B-cell responses to breast cancer Cancer Immunol Immunother 52 715 738 12920480 10.1007/s00262-003- 0409-4 (Pubitemid 37491701)
16. + B cells: the other tumor-infiltrating lymphocytes J Immunol 185 4977 4982 20962266 10.4049/jimmunol.1001323 1:CAS:528:DC%2BC3cXhtlWiu7fJ
17. P Hersey E Murray J Grace WH McCarthy 1985 Current research on immunopathology of melanoma: analysis of lymphocyte populations in relation to antigen expression and histological features of melanoma Pathology 17 385 391 2866482 10.3109/00313028509105490 1:STN:280:DyaL28%2Fms1Oktw%3D%3D (Pubitemid 15242562)
18. E Ralfkaier K Hou-Jensen KC Gatter KT Drzewiecki DY Mason 1987 Immunohistological analysis of the lymphoid infiltrate in cutaneous malignant melanomas Virchow Arch A 410 355 361 10.1007/BF00711292 (Pubitemid 17014611)
19. MR Hussein DAH Elsers SA Fadel A-EM Omar 2006 Immunohistological characterization of tumour infiltrating lymphocytes in melanocytic skin lesions J Clin Pathol 59 316 324 16505286 10.1136/jcp.2005.028860 1:STN:280: DC%2BD287hslyrtA%3D%3D (Pubitemid 43344897)
20. A Ladányi B Somlai K Gilde Z Fejös I Gaudi J Tímár 2004 T-cell activation marker expression on tumor-infiltrating lymphocytes as prognostic factor in cutaneous malignant melanoma Clin Cancer Res 10 521 530 14760073 10.1158/1078-0432.CCR-1161-03 (Pubitemid 38173990)
21. + mature dendritic cells in combination with activated T lymphocytes infiltrating primary cutaneous melanoma is a strong independent prognostic factor Cancer Immunol Immunother 56 1459 1469 17279413 10.1007/s00262-007-0286-3 (Pubitemid 47024707)
22. CM Balch AC Buzaid S-J Soong MB Atkins N Cascinelli DG Coit ID Fleming JE Gershenwald A Houghton Jr JM Kirkwood KM McMasters MF Mihm DL Morton DS Reintgen MI Ross A Sober JA Thompson JF Thompson 2001 Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma J Clin Oncol 19 3635 3648 11504745 1:STN:280:DC%2BD3MvlvV2ktQ%3D%3D (Pubitemid 32786276)
23. J Kiss J Tímár B Somlai K Gilde Z Fejos I Gaudi A Ladányi 2007 Association of microvessel density with infiltrating cells in human cutaneous malignant melanoma Pathol Oncol Res 13 21 31 17387385 10.1007/BF02893437 (Pubitemid 46883543)
24. MH Hansen H Nielsen HJ Ditzel 2001 The tumor-infiltrating B cell response in medullary breast cancer is oligoclonal and directed against the autoantigen actin exposed on the surface of apoptotic cancer cells Proc Natl Acad Sci USA 98 12659 12664 11606714 10.1073/pnas.171460798 1:CAS:528:DC%2BD3MXotFaiu7g%3D (Pubitemid 33020002)
25. PM O'Brien E Tsirimonaki DW Coomber DW Millan JA Davis MS Campo 2001 Immunoglobulin genes expressed by B-lymphocytes infiltrating cervical carcinoma show evidence of antigen-driven selection Cancer Immunol Immunother 50 523 532 11776374 10.1007/s00262-001-0234-6 (Pubitemid 34028285)
26. JA Coronella P Tellemann GA Kingsbury TD Truong S Hays RP Junghans 2001 Evidence for an antigen-driven humoral immune response in medullary ductal breast cancer Cancer Res 61 7889 7899 11691809 1:CAS:528:DC%2BD3MXotlarsr4%3D (Pubitemid 33050986)
27. JA Coronella C Spier M Welch KT Trevor AT Stopeck H Villar EM Hersh 2002 Antigen-driven oligoclonal expansion of tumor-infiltrating B cells in infiltrating ductal carcinoma of the breast J Immunol 169 1829 1836 12165506 1:CAS:528:DC%2BD38XmtFejs7o%3D (Pubitemid 34857644)
28. S Nzula JJ Going DI Stott 2003 Antigen-driven clonal proliferation, somatic hypermutation, and selection of B lymphocytes infiltrating human ductal breast carcinomas Cancer Res 63 3275 3280 12810659 1:CAS:528: DC%2BD3sXks1eiu7g%3D (Pubitemid 36735883)
29. NM Yeilding C Gerstner JM Kirkwood 1992 Analysis of two human monoclonal antibodies against melanoma Int J Cancer 52 967 973 1459738 10.1002/ijc. 2910520623 1:STN:280:DyaK3s%2FptlyjtQ%3D%3D (Pubitemid 23009517)
30. CJA Punt JAM Barbuto H Zhang WJ Grimes KD Hatch EM Hersh 1994 Anti-tumor antibody produced by human tumor-infiltrating and peripheral blood B lymphocytes Cancer Immunol Immunother 38 225 232 8168117 10.1007/BF01533513 1:CAS:528:DyaK2cXkvVSntbc%3D (Pubitemid 24108733)
31. B Kotlan P Simsa J-L Teillaud WH Fridman J Toth M McKnight MC Glassy 2005 Novel ganglioside antigen identified by B cells in human medullary breast carcinomas: the proof of principle concerning the tumor-infiltrating B lymphocytes J Immunol 175 2278 2285 16081796 1:CAS:528:DC%2BD2MXntVSrurw%3D (Pubitemid 41113835)
32. M-C Dieu-Nosjean M Antoine C Danel D Heudes M Wislez V Poulot N Rabbe L Laurans E Tartour L de Chaisemartin S Lebecque W-H Fridman J Cadranel 2008 Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures J Clin Oncol 26 4410 4417 18802153 10.1200/JCO.2007.15.0284 1:CAS:528:DC%2BD1cXht1ejur7F
33. A Suzuki A Masuda H Nagata S Kameoka Y Kikawada M Yamakawa T Kasajima 2002 Mature dendritic cells make clusters with T cells in the invasive margin of colorectal carcinoma J Pathol 196 37 43 11748640 10.1002/path.1018 (Pubitemid 34071577)
34. KE de Visser LV Korets LM Coussens 2005 De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent Cancer Cell 7 411 423 15894262 10.1016/j.ccr.2005.04.014 1:CAS:528:DC%2BD2MXkslyit7k%3D (Pubitemid 40719125)
35. P Brodt J Gordon 1978 Anti-tumor immunity in B lymphocyte-deprived mice. I. immunity to a chemically induced tumor J Immunol 121 359 362 307580 1:STN:280:DyaE1c3hvFartw%3D%3D (Pubitemid 8384890)
36. Z Qin G Richter T Schüler S Ibe X Cao T Blankenstein 1998 B cells inhibit induction of T cell-dependent tumor immunity Nat Med 4 627 630 9585241 10.1038/nm0598-627 1:CAS:528:DyaK1cXjtFKgtrY%3D (Pubitemid 28237366)
37. H 1 cytokine responses by B cells Int J Cancer 117 574 586 15912532 10.1002/ijc.21177 1:CAS:528:DC%2BD2MXhtFKjs7rE (Pubitemid 41504545)
38. KR Schultz JP Klarnet RS Gieni KT HayGlass PD Greenberg 1990 The role of B cells for in vivo T cell responses to a Friend virus-induced leukemia Science 249 921 923 2118273 10.1126/science.2118273 1:STN:280:DyaK3czmsVCisA%3D%3D
39. + T cell tumor immunity: therapeutic B cell depletion enhances B16 melanoma growth in mice J Immunol 184 4006 4016 20194720 10.4049/jimmunol.0903009 1:CAS:528:DC%2BC3cXjs1Wqs74%3D
40. N Kaliss 1958 Immunological enhancement of tumor homografts in mice: a review Cancer Res 18 992 1003 13596939 1:STN:280:DyaG1M%2Fis1ensw%3D%3D
41. FA Salinas KH Wee 1986 Prognostic and pathogenetic implications of immune complexes in human cancer Adv Immun Cancer Ther 2 189 209 2962476 1:STN:280:DyaL1c7gtlShsQ%3D%3D
42. M Johansson DG DeNardo LM Coussens 2008 Polarized immune responses differentially regulate cancer development Immunol Rev 222 145 154 18363999 10.1111/j.1600-065X.2008.00600.x 1:CAS:528:DC%2BD1cXlsFejtrY%3D (Pubitemid 351430362)
43. R Lapointe A Bellemare-Pelletier F Housseau J Thibodeau P Hwu 2003 CD40-stimulated B lymphocytes pulsed with tumor antigens are effective antigen-presenting cells that can generate specific T cells Cancer Res 63 2836 2843 12782589 1:CAS:528:DC%2BD3sXkt1aisLw%3D (Pubitemid 36667155)
44. Q Li AC Grover EJ Donald A Carr J Yu J Whitfield M Nelson N Takeshita AE Chang 2005 Simultaneous targeting of CD3 on T cells and CD40 on B or dendritic cells augments the antitumor reactivity of tumor-primed lymph node cells J Immunol 175 1424 1432 16034078 1:CAS:528:DC%2BD2MXmtlWjtrw%3D (Pubitemid 41023041)
45. P-J Linton J Harbertson LM Bradley 2000 A critical role for B cells in the development of memory CD4 cells J Immunol 165 5558 5565 11067910 1:CAS:528:DC%2BD3cXot1Grs70%3D
46. A Rivera CC Chen N Ron JP Dougherty Y Ron 2001 Role of B cells as antigen-presenting cells in vivo revisited: antigen-specific B cells are essential for T cell expansion in lymph nodes and for systemic T cell responses to low antigen concentrations Int Immunol 13 1583 1593 11717199 10.1093/intimm/13.12.1583 1:CAS:528:DC%2BD3MXptVKmt7k%3D (Pubitemid 33133885)
47. P-J Linton B Bautista E Biederman ES Bradley J Harbertson RM Kondrack RC Padrick LM Bradley 2003 Costimulation via OX40L expressed by B cells is sufficient to determine the extent of primary CD4 cell expansion and Th2 cytokine secretion in vivo J Exp Med 197 875 883 12668647 10.1084/jem.20021290 1:CAS:528:DC%2BD3sXivFaisb4%3D (Pubitemid 36437864)
48. M Reuschenbach M von Knebel Doeberitz N Wentzensen 2009 A systematic review of humoral immune response against tumor antigens Cancer Immunol Immunother 58 1535 1544 19562338 10.1007/s00262-009-0733-4 1:CAS:528: DC%2BD1MXptVentr4%3D
49. K Milne M Köbel SE Kalloger RO Barnes D Gao CB Gilks PH Watson BH Nelson 2009 Systematic analysis of immune infiltrates in high-grade serous ovarian cancer reveals CD20, FoxP3 and TIA-1 as positive prognostic factors PLoS One 4 e6412 19641607 10.1371/journal.pone.0006412